Join
Live feed
·
INSIDERFilingvia Quantisnow
Silexion Therapeutics Corp logo

Director Levin Ilan disposed of 5,550 units of Ordinary Shares and was granted 450,000 units of Ordinary Shares (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
SLXN· Silexion Therapeutics Corp
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track SLXN (Silexion Therapeutics Corp) and more on Quantisnow.